{
  "cases": [
    {
      "case_id": "MDT-001",
      "patient_id": "P-1001",
      "patient_name": "Sarah Johnson",
      "diagnosis": "Invasive Ductal Carcinoma",
      "stage": "Stage IIB",
      "diagnosticore_case_submitter_id": "TCGA-A1-A0SP",
      "imaging": {
        "ct_report": "CT chest/abdomen/pelvis shows no distant metastatic disease; left axillary nodal enlargement noted.",
        "mri_report": "Breast MRI demonstrates 2.8 cm irregular enhancing lesion in upper outer quadrant with suspicious node morphology.",
        "pet_report": "FDG uptake confined to primary lesion and ipsilateral nodal basin."
      },
      "pathology": {
        "biopsy_summary": "Core biopsy: Grade 3 invasive ductal carcinoma.",
        "wsi_summary": "High cellularity with pleomorphic nuclei and increased mitotic activity.",
        "receptor_status": "ER low positive, PR negative, HER2 3+, Ki-67 22%",
        "grade": "3"
      },
      "genomics": {
        "report_summary": "NGS identifies PIK3CA H1047R and TP53 R248Q; low TMB; MSI stable.",
        "mutations": [
          {
            "gene": "PIK3CA",
            "variant": "H1047R",
            "tier": "I",
            "notes": "Actionable pathway mutation"
          },
          {
            "gene": "TP53",
            "variant": "R248Q",
            "tier": "II",
            "notes": "High-risk association"
          }
        ],
        "tmb": "Low",
        "msi": "Stable"
      },
      "transcript": {
        "raw_text": "48-year-old woman with stage IIB invasive ductal carcinoma, presenting with two positive axillary lymph nodes. Breast MRI shows a 2.8 cm irregular enhancing lesion in the upper outer quadrant, with no evidence of chest wall invasion. There is one suspicious ipsilateral axillary lymph node. Core biopsy confirms grade 3 invasive ductal carcinoma. Oestrogen receptor is low positive at 10 percent, progesterone receptor is negative, HER2 is 3 positive, and Ki-67 is 22 percent. Molecular panel reports a PIK3CA H1047R mutation and a TP53 R248Q mutation. Tumour mutational burden is low, and microsatellite status is stable. Given the HER2 positivity and nodal disease, the recommendation is to proceed with neoadjuvant anti-HER2 systemic therapy prior to surgery. The team agrees with a neoadjuvant approach, followed by restaging and definitive surgical planning. Consensus is to proceed with neoadjuvant anti-HER2 regimen, reassess response, and then perform definitive surgery.",
        "audio_uri": ""
      }
    },
    {
      "case_id": "MDT-002",
      "patient_id": "P-1002",
      "patient_name": "David Kim",
      "diagnosis": "NSCLC Adenocarcinoma",
      "stage": "Stage IIIA",
      "diagnosticore_case_submitter_id": "TCGA-A2-A1FX",
      "imaging": {
        "ct_report": "Right upper lobe spiculated mass 3.4 cm with ipsilateral mediastinal nodes.",
        "mri_report": "No brain metastases identified.",
        "pet_report": "Primary lesion and mediastinal nodes FDG-avid; no distant uptake."
      },
      "pathology": {
        "biopsy_summary": "EBUS biopsy confirms adenocarcinoma consistent with lung primary.",
        "wsi_summary": "Gland-forming malignant cells with stromal reaction.",
        "receptor_status": "PD-L1 TPS 65%",
        "grade": "2"
      },
      "genomics": {
        "report_summary": "KRAS G12C detected; EGFR/ALK/ROS1 negative; intermediate mutational risk profile.",
        "mutations": [
          {
            "gene": "KRAS",
            "variant": "G12C",
            "tier": "I",
            "notes": "Targetable in advanced settings"
          }
        ],
        "tmb": "Intermediate",
        "msi": "Stable"
      },
      "transcript": {
        "raw_text": "Thoracic surgery: potentially resectable after induction. Medical oncology: recommend induction chemo-immunotherapy then restaging.",
        "audio_uri": "gs://voxelomics-mdt/mock/mdt-002.wav"
      }
    },
    {
      "case_id": "MDT-003",
      "patient_id": "P-1003",
      "patient_name": "Grace Williams",
      "diagnosis": "High-Grade Serous Ovarian Cancer",
      "stage": "Stage IIIC",
      "diagnosticore_case_submitter_id": "TCGA-A2-A0SV",
      "imaging": {
        "ct_report": "Peritoneal implants and omental disease with moderate ascites.",
        "mri_report": "Bilateral adnexal masses with diffuse peritoneal involvement.",
        "pet_report": "Widespread peritoneal FDG uptake pattern."
      },
      "pathology": {
        "biopsy_summary": "High-grade serous carcinoma, WT1 positive, aberrant p53.",
        "wsi_summary": "Marked atypia and brisk mitotic activity.",
        "receptor_status": "Not applicable",
        "grade": "3"
      },
      "genomics": {
        "report_summary": "HRD-positive profile with BRCA1 pathogenic alteration.",
        "mutations": [
          {
            "gene": "BRCA1",
            "variant": "Pathogenic truncating variant",
            "tier": "I",
            "notes": "Therapeutic relevance for PARP pathway"
          }
        ],
        "tmb": "Low",
        "msi": "Stable"
      },
      "transcript": {
        "raw_text": "Gynecologic oncology: discuss interval debulking after three cycles platinum. Genetics: family counseling advised.",
        "audio_uri": "gs://voxelomics-mdt/mock/mdt-003.wav"
      }
    }
  ]
}
